NextGenics
ActiveSummary
NextGenics has been active since 2020 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €39,298 and a net result of -€13,279. Equity is shrinking by about 16% per year and would, assuming unchanged policy, indicatively turn negative around financial year 2028. Its solvency ranks better than 40% of 21,007 sector peers (NACE 62, financial year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).
History
Acts, filings and financial milestones
Next filing, financial year 2026, expected by
2026
28-07
NBB filing
Annual accounts filed
financial year 2025 · micro format
2025
24-07
NBB filing
Annual accounts filed
financial year 2024 · micro format
2024
31-12
Financial
Weakest financial yearnet -€48,811
Net result drops to -€48,811, the lowest in the series; recovery starts the following year.
30-08
NBB filing
Annual accounts filed
financial year 2023 · micro format · 30 days late
05-02
NBB filing
Annual accounts filed
financial year 2022 · micro format · 189 days late
2023
31-12
Financial
Back to profitnet €1,131
Net result €1,131 after one loss-making year.
2022
26-08
NBB filing
Annual accounts filed
financial year 2021 · micro format · 26 days late
Financial milestoneNBB filingFinancial milestones sit on the financial year-end date, not the filing date.
0 of 3 deeds read
About the unread acts
We know of 3 Belgian Official Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.